Israel 150 Logo

Israeli companies listed on US stock exchanges

Brainstorm Cell Therapeutics Inc. (BCLI)

Brainstorm Cell Therapeutics

Sector: Medical

Industry: Medical - Biomedical and Genetics

Exchange: Nasdaq

1325 Avenue of Americas 28th Floor New York, NY 10019 United States

IR Contact info

Name: Uri Yablonka

Title: Executive VP, Chief Business Officer


Tel: (646) 666-3188

BCLI on Major Financial Platforms:
  • Nasdaq

BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Alzheimer's Disease (AD).

The Executives
Prof. Jacob Frenkel,Chairman of the Board
Chaim Lebovits,President & CEO
Uri Yablonka,Executive VP, Chief Business Officer
Video Presentations
PP Presentation
NurOwn for ALS